LRRC39
Leucine-rich repeat-containing protein 39
Also known as: LRC39_HUMAN, MGC14816, myomasp
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96DD0
- Gene
- LRRC39
- Ensembl
- ENSG00000122477
- Chromosome
- 1
- Canonical length
- 335 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be involved in intracellular signal transduction. Predicted to be located in M band. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
335 residues, UniProt reviewed canonical sequence.
>Q96DD0|LRRC39
1 MTENVVCTGA VNAVKEVWEK RIKKLNEDLK REKEFQHKLV RIWEERVSLT KLREKVTRED
61 GRVILKIEKE EWKTLPSSLL KLNQLQEWQL HRTGLLKIPE FIGRFQNLIV LDLSRNTISE
121 IPPGIGLLTR LQELILSYNK IKTVPKELSN CASLEKLELA VNRDICDLPQ ELSNLLKLTH
181 LDLSMNDFTT IPLAVLNMPA LEWLDMGSNK LEQLPDTIER MQNLHTLWLQ RNEITCLPQT
241 ISNMKNLGTL VLSNNKLQDI PVCMEEMANL RFVNFRDNPL KLKVSLPPSE GTDEEEEREL
301 FGLQFMHTYI QESRRRADHQ VNGSTTLPIS INTDGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRC39 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 404 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 404 nTPM
- tongue: 161 nTPM
- retina: 109 nTPM
- heart muscle: 100 nTPM
- adrenal gland: 7.9 nTPM
- testis: 5.3 nTPM
Single-cell type
- myonuclei: 784 nCPM
- rod photoreceptor cells: 357 nCPM
- cone photoreceptor cells: 302 nCPM
- late primary spermatocytes: 282 nCPM
- hofbauer cells: 247 nCPM
- cardiomyocytes: 150 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 8.7 nTPM
- cerebral cortex: 8.2 nTPM
- medulla oblongata: 8 nTPM
- hypothalamus: 7.8 nTPM
- basal ganglia: 7.5 nTPM
- amygdala: 7.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRRC39 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRC39 as an antibody target. Whether an autoantibody or antibody against LRRC39 could matter depends on whether native LRRC39 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRC39 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRRC39 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...